More funding for billionaire Patrick Soon-Shiong’s NantBioscience has been reported to the SEC – to the tune of $100 million this time. NantBioscience is the division of Soon-Shiong’s umbrella company, NantWorks, that centers on precision medicine. Los Angeles-based NantWorks has more than $1 billion in funding behind it since its launch last year, but it’s interesting to […]
Given billionaire Patrick Soon-Shiong’s general save-the-world M.O., it’s always worth tracking what his companies are up to. NantBioScience, an offshoot of his Los Angeles startup NantWorks, has partnered up with University of Colorado to develop protein-targeted anti-cancer drugs and diagnostics. The licensing deal is exclusive, and focuses on the Ral protein – which plays a role across activated signaling pathways in pancreatic, lung, colon and other […]
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.